Pulmonary arterial hypertension registries: past, present and into the future
作者: Jason WeatheraldAbílio ReisOlivier SitbonMarc Humbert
作者单位: 1Dept of Medicine, Division of Respiratory Medicine, University of Calgary, Calgary, AB, Canada
2Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada
3Pulmonary Vascular Disease Unit, Medicine Dept, Centro Hospitalar Universitário do Porto, Hospital de Santo António, Porto, Portugal
4Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France
5Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France
6INSERM UMR S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France
刊名: European Respiratory Review, 2019, Vol.28 (154)
来源数据库: European Respiratory Society
DOI: 10.1183/16000617.0128-2019
原始语种摘要: Disease registries are important sources of real-world evidence that inform clinical practice and health policy, particularly when randomised controlled trials do not exist [1]. Much of what we know today about pulmonary arterial hypertension (PAH) has come from observational studies from national and/or international disease registries.
全文获取路径: ERS  (合作)

  • hypertension 高血压
  • past 过去
  • arterial 动脉的
  • present 出席的
  • future 将来
  • observational 观察的
  • national 国家的
  • policy 政策
  • today 今天
  • particularly 特别